Audrey Bellesoeur
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
The hidden impact of renal impairment on ribociclib exposure and co-medications: a case report.
Journal: Cancer chemotherapy and pharmacology
Published: December 19, 2025
Inavolisib plus fulvestrant-palbociclib - advanced or metastatic breast cancers hormone receptor-positive, HER2-negative, PIK3CA-mutated, endocrine-resistant, in the first-line setting
Journal: Bulletin du cancer
Published: November 09, 2025
The misleading accuracy of propofol PK/PD models: why hypoalbuminemia matters.
Journal: Expert opinion on drug metabolism & toxicology
Published: September 26, 2025
Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals.
Journal: Scientific reports
Published: March 25, 2025
Improving olaparib exposure to optimize adverse effects management.
Journal: Therapeutic advances in medical oncology
Published: January 17, 2024
Adjuvant olaparib - High risk early breast cancer with BRCA1 or BRCA2 germline mutation
Journal: Bulletin du cancer
Published: April 26, 2023
Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach.
Journal: British journal of clinical pharmacology
Published: February 25, 2023
Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 13, 2023
Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy.
Journal: European radiology
Published: December 15, 2022
Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals.
Journal: Cancers
Published: March 22, 2022
Last Updated: 09/26/2026